Blocking these signals could prevent splicing and inclusion of CE3, leading to the expression of a full-length AR mRNA (AR-FL) and this potentially could be used as a mean to re-sensitize tumor cells to current androgen deprivation therapy. The gene discussed is AR; the disease is neoplasm.